跳到主要內容

臺灣博碩士論文加值系統

(44.213.60.33) 您好!臺灣時間:2024/07/18 09:10
字體大小: 字級放大   字級縮小   預設字形  
回查詢結果 :::

詳目顯示

我願授權國圖
: 
twitterline
研究生:黃彩雲
研究生(外文):Tsai-Yun Huang
論文名稱:貝他型腫瘤壞死因子NcoI基因多樣性與大腸癌的關聯性
論文名稱(外文):The association of tumor necrosis factor beta-NcoI polymorphism with colorectal cancer
指導教授:許立松
學位類別:碩士
校院名稱:中山醫學大學
系所名稱:生化暨生物科技研究所
學門:生命科學學門
學類:生物科技學類
論文種類:學術論文
論文出版年:2013
畢業學年度:101
語文別:中文
論文頁數:54
相關次數:
  • 被引用被引用:0
  • 點閱點閱:121
  • 評分評分:
  • 下載下載:0
  • 收藏至我的研究室書目清單書目收藏:0
大腸直腸癌是全世界第三個最常見的癌症,在台灣地區的罹患率
也高居第二位,而其癌症死亡率居第三位。過去的文獻已經提出相關的危險因子包括年齡的增加、性別(男性較易罹患大腸直腸癌)、發炎性腸道疾病、某些遺傳性條件和大腸直腸癌的家族史,都可能是導致大腸直腸癌的發生。有許多研究證實,單一核苷酸多型性與某些癌症和疾病的產生是有關聯性的。腫瘤壞死因子 (TNF) 是一種能直接造成腫瘤細胞死亡的細胞激素,它可啟動控制細胞增殖和凋亡的信號,以防止細胞炎症、自體免疫疾病或惡性腫瘤的發病過程。而 TNF-β 則是屬於腫瘤壞死因子家族的一員,當淋巴球被刺激產生分泌型 LTα (TNF-β) 後,它與 TNFR1 或 TNFR2 結合,引發細胞凋亡或活化典型 nuclear factor kappa-B (NFκB) 路徑造成發炎基因表現或淋巴再生,目前經許多研究都證實這個 TNF-β 的基因多型性與各種惡性疾病的發生是有關的。因此,本次實驗是針對TNF-β基因多型性與大腸直腸癌之間的相關性進行探討。利用聚合酶連鎖反應-限制酶切割片段長度多型性分析55位大腸癌患者其TNF-β多型性之等位基因的頻率,接著再與134位健康的對照組(IIA,無任何病史者,N = 58;IIB,具有傳統心血管疾病危險因子的病患,N = 76)進行統計分析。實驗結果顯示TNF-β genotype 之 G/G 同型合子與 genotype AG+AA 在實驗組 Group CRC 與對照組 Group ⅡA (無任何病史) 之間的結果具有顯著性的差異 (P 值 = 0.035)。我們的研究是首先提出在台灣地區的人群中 TNF-β NcoI 基因多型性與大腸直腸癌的發生是有關聯性的。

Colorectal cancer represents the third most common cancer
worldwide, and also the second highest prevalence, and its ranks third in cancer mortality in Taiwan region. It has been proposed that risk factors for colorectal cancer include increased age, gender (men are more predisposed to the development of colorectal cancer), the presence of inflammatory bowel disease, certain hereditary conditions and a family history of colorectal cancer. There are many studies indicated that single nucleotide polymorphism (SNPs) are associated with some cancers and diseases. Tumor necrosis factor (TNF) is a kind of cytokine which cause tumor cell death directly. It can initiate signals for cell proliferation and apoptosis (programmed cell death) to prevent inflammation, autoimmune diseases or cancer pathogenesis. TNF-β belongs to the TNF superfamily. When lymphocytes are stimulated to produce secretory LTα (TNF-β), it can interact with TNFR1 or TNFR2, resulting in apoptosis or NF-κB–dependent activation of inflammatory genes or events leading to lymphoid neogenesis. Many current studies have been confirmed that TNF-β gene polymorphism is associated various malignant diseases. In this study, we investigated the possible association of TNF-β gene polymorphism with colorectal cancer in Taiwan region. Using polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP), the allele frequency of the TNF-β polymorphism was investigated in 55 patients with colorectal cancer and 134 healthy control ( group IIA, without disease risks, n = 58; group IIB, personnel don’t have any conventional cardiovascular disease risk factors, n = 76). Experimental results show that TNF-β G/G genotype homozygous vs AG + AA genotype in both the experimental group CRC and control group IIA have significant difference (P-value = 0.035). Our study presents preliminary but intriguing data suggesting that TNF-β NcoI may be associated with CRC formation in Taiwan region.

壹、縮寫檢索.............................1
貳、中文摘要.............................2
參、英文摘要.............................4
肆、緒論.................................6
一、 大腸直腸癌的介紹................8
(一) 大腸的構造與功能...................8
(二) 流行病學...........................9
(三) 致癌機轉...........................11
(四) 可能的致癌因素.....................12
(五) 診斷方式...........................15
(六) 大腸直腸癌的分期...................16
(七) 治療的方式.........................17
(八) 大腸直腸癌的篩檢與防治.............18
二、 基因多型性與大腸直腸癌..........19
三、 腫瘤壞死因子 (Tumor Necrosis Factor, TNF) 介紹
(一) TNF的分類.......................... 21
(二) TNF-β 的生物活性................... 22
(三) TNF-β 的訊息傳遞....................23
四、 TNF-β 與人類癌症的關聯...........24
伍、研究背景與目的........................26
陸、實驗材料與方法........................28
柒、實驗結果..............................36
捌、討論..................................39
玖、參考文獻..............................42
拾、圖表..................................47
拾壹、附圖表..............................51


1.99年癌症登記報告, 行 政 院 衛 生 署 國 民 健 康 局 編 印. 2013: p. 2-37.
2.中華民國100年死因統計, 行政院衛生署. 2012.
3.Fung, K.Y., et al., Colorectal Carcinogenesis: A Cellular Response to Sustained Risk Environment. Int J Mol Sci, 2013. 14(7): p. 13525-13541.
4.Aune, D., et al., Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies. BMJ, 2011. 343: p. d6617.
5.Martinez-Uruena, N., et al., Incidence of -93 MLH1 promoter polymorphism in familial and sporadic colorectal cancer. Colorectal Dis, 2013. 15(3): p. e118-23.
6.結腸直腸癌手冊馬偕紀念醫院, 癌症防治中心 編印.
7.Ferlay, J., et al., Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 2010. 127(12): p. 2893-917.
8.Sameer, A.S., et al., TP53 Pro47Ser and Arg72Pro polymorphisms and colorectal cancer predisposition in an ethnic Kashmiri population. Genet Mol Res, 2010. 9(2): p. 651-60.
9.Facista, A., et al., Deficient expression of DNA repair enzymes in early progression to sporadic colon cancer. Genome Integr, 2012. 3(1): p. 3.
10.結腸直腸癌手冊長庚紀念醫院, 癌症中心編印.
11.Ibrahim, K.O., et al., Morphology of colorectal carcinoma among Nigerians: a 30-year review. Niger J Clin Pract, 2011. 14(4): p. 432-5.
12.Sipos, F., G. Valcz, and B. Molnar, Physiological and pathological role of local and immigrating colonic stem cells. World J Gastroenterol, 2012. 18(4): p. 295-301.
13.Cunningham, D., et al., Colorectal cancer. Lancet, 2010. 375(9719): p. 1030-47.
14.Migliore, L., et al., Genetics, cytogenetics, and epigenetics of colorectal cancer. J Biomed Biotechnol, 2011. 2011: p. 792362.
15.Yang, J., J.Y. Peng, and W. Chen, Synchronous colorectal cancers: a review of clinical features, diagnosis, treatment, and prognosis. Dig Surg, 2011. 28(5-6): p. 379-85.
16.Lin, J.S., et al., in Fecal DNA Testing in Screening for Colorectal Cancer in Average-Risk Adults. 2012: Rockville (MD).
17.Bai, Y.H., et al., Vitamin D receptor gene polymorphisms and colorectal cancer risk: a systematic meta-analysis. World J Gastroenterol, 2012. 18(14): p. 1672-9.
18.Aiello, M., et al., Role of genetic polymorphisms and mutations in colorectal cancer therapy (Review). Mol Med Rep, 2011. 4(2): p. 203-8.
19.Martin de Civetta, M.T. and J.D. Civetta, [Carcinogenesis]. Salud Publica Mex, 2011. 53(5): p. 405-14.
20.Sugimura, T. and M. Terada, Experimental chemical carcinogenesis in the stomach and colon. Jpn J Clin Oncol, 1998. 28(3): p. 163-7.
21.Carvalho, B., et al., Colorectal adenoma to carcinoma progression is accompanied by changes in gene expression associated with ageing, chromosomal instability, and fatty acid metabolism. Cell Oncol (Dordr), 2012. 35(1): p. 53-63.
22.Tantamango, Y.M., et al., Association between dietary fiber and incident cases of colon polyps: the adventist health study. Gastrointest Cancer Res, 2011. 4(5-6): p. 161-7.
23.Jarvinen, H.J., Hereditary cancer: guidelines in clinical practice. Colorectal cancer genetics. Ann Oncol, 2004. 15 Suppl 4: p. iv127-31.
24.Vasovcak, P., et al., Molecular genetic analysis of 103 sporadic colorectal tumours in Czech patients. PLoS One, 2011. 6(8): p. e24114.
25.Liu, L., et al., Interactions between genetic variants in the adiponectin, adiponectin receptor 1 and environmental factors on the risk of colorectal cancer. PLoS One, 2011. 6(11): p. e27301.
26.Wong, H.P., et al., Nicotine promotes colon tumor growth and angiogenesis through beta-adrenergic activation. Toxicol Sci, 2007. 97(2): p. 279-87.
27.Na, S.Y. and S.J. Myung, [Obesity and colorectal cancer]. Korean J Gastroenterol, 2012. 59(1): p. 16-26.
28.Brevik, A., et al., Polymorphisms in base excision repair genes as colorectal cancer risk factors and modifiers of the effect of diets high in red meat. Cancer Epidemiol Biomarkers Prev, 2010. 19(12): p. 3167-73.
29.Terzic, J., et al., Inflammation and colon cancer. Gastroenterology, 2010. 138(6): p. 2101-2114 e5.
30.Jang, E. and D.C. Chung, Hereditary colon cancer: lynch syndrome. Gut Liver, 2010. 4(2): p. 151-60.
31.Wiesner, G.L., et al., A subset of familial colorectal neoplasia kindreds linked to chromosome 9q22.2-31.2. Proc Natl Acad Sci U S A, 2003. 100(22): p. 12961-5.
32.Watson, A.J. and P.D. Collins, Colon cancer: a civilization disorder. Dig Dis, 2011. 29(2): p. 222-8.
33.Lee, S.Y., et al., Association of CTTN polymorphisms with the risk of colorectal cancer. J Korean Surg Soc, 2012. 82(3): p. 156-64.
34.Goel, A. and C.R. Boland, Recent insights into the pathogenesis of colorectal cancer. Curr Opin Gastroenterol, 2010. 26(1): p. 47-52.
35.Slattery, M.L., et al., Increased risk of colon cancer associated with a genetic polymorphism of SMAD7. Cancer Res, 2010. 70(4): p. 1479-85.
36.Li, L., et al., Association between phosphatidylinositol 3-kinase regulatory subunit p85alpha Met326Ile genetic polymorphism and colon cancer risk. Clin Cancer Res, 2008. 14(3): p. 633-7.
37.Azimzadeh, P., et al., Interleukin-16 (IL-16) gene polymorphisms in Iranian patients with colorectal cancer. J Gastrointestin Liver Dis, 2011. 20(4): p. 371-6.
38.Lee, K.E., et al., p73 G4C14 to A4T14 polymorphism is associated with colorectal cancer risk and survival. World J Gastroenterol, 2010. 16(35): p. 4448-54.
39.Messer, G., et al., Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production. J Exp Med, 1991. 173(1): p. 209-19.
40.Komori, A., et al., Tumor necrosis factor acts as a tumor promoter in BALB/3T3 cell transformation. Cancer Res, 1993. 53(9): p. 1982-5.
41.Wolf, M.J., et al., The unexpected role of lymphotoxin beta receptor signaling in carcinogenesis: from lymphoid tissue formation to liver and prostate cancer development. Oncogene, 2010. 29(36): p. 5006-18.
42.Tracey, D., et al., Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. Pharmacol Ther, 2008. 117(2): p. 244-79.
43.Porto, I., et al., Inflammation, genetics, and ischemic heart disease: focus on the major histocompatibility complex (MHC) genes. Cytokine, 2005. 29(5): p. 187-96.
44.Zhang, D., et al., Association of two polymorphisms of tumor necrosis factor gene with acute severe pancreatitis. J Surg Res, 2003. 112(2): p. 138-43.
45.Schneider, K., K.G. Potter, and C.F. Ware, Lymphotoxin and LIGHT signaling pathways and target genes. Immunol Rev, 2004. 202: p. 49-66.
46.Wilson, A.G., F.S. di Giovine, and G.W. Duff, Genetics of tumour necrosis factor-alpha in autoimmune, infectious, and neoplastic diseases. J Inflamm, 1995. 45(1): p. 1-12.
47.Menke, V., et al., NcoI TNF-beta gene polymorphism and TNF expression are associated with an increased risk of developing Barrett''s esophagus and esophageal adenocarcinoma. Scand J Gastroenterol, 2012. 47(4): p. 378-86.
48.Tselepis, C., et al., Tumour necrosis factor-alpha in Barrett''s oesophagus: a potential novel mechanism of action. Oncogene, 2002. 21(39): p. 6071-81.
49.Bazzoni, F. and B. Beutler, The tumor necrosis factor ligand and receptor families. N Engl J Med, 1996. 334(26): p. 1717-25.
50.Balkwill, F. and L.M. Coussens, Cancer: an inflammatory link. Nature, 2004. 431(7007): p. 405-6.
51.Dranoff, G., Cytokines in cancer pathogenesis and cancer therapy. Nat Rev Cancer, 2004. 4(1): p. 11-22.
52.Bouma, G., et al., Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease. Scand J Immunol, 1996. 43(4): p. 456-63.
53.Li, C., et al., TNF gene polymorphisms and Helicobacter Pylori infection in gastric carcinogenesis in Chinese population. Am J Gastroenterol, 2005. 100(2): p. 290-4.
54.Lanas, A., et al., TNF and LTA gene polymorphisms reveal different risk in gastric and duodenal ulcer patients. Genes Immun, 2001. 2(8): p. 415-21.
55.Park, K.S., et al., Polymorphisms of tumour necrosis factors A and B in breast cancer. Eur J Immunogenet, 2002. 29(1): p. 7-10.
56.Nonomura, N., et al., Possible correlation between polymorphism in the tumor necrosis factor-beta gene and the clinicopathological features of bladder cancer in Japanese patients. Int J Urol, 2006. 13(7): p. 971-6.
57.Zhang, D.L., et al., Association of two polymorphisms of tumor necrosis factor gene with acute biliary pancreatitis. World J Gastroenterol, 2003. 9(4): p. 824-8.
58.Majetschak, M., et al., Relation of a TNF gene polymorphism to severe sepsis in trauma patients. Ann Surg, 1999. 230(2): p. 207-14.
59.Li, M., Q. You, and X. Wang, Association between polymorphism of the tumor necrosis factor alpha-308 gene promoter and colon cancer in the Chinese population. Genet Test Mol Biomarkers, 2011. 15(11): p. 743-7.
60.Wu, G.Y., et al., [Association between tumor necrosis factor alpha gene polymorphism and colorectal cancer]. Zhonghua Wei Chang Wai Ke Za Zhi, 2008. 11(6): p. 569-71.
61.Zheng, X., et al., The SNP rs961253 in 20p12.3 is associated with colorectal cancer risk: a case-control study and a meta-analysis of the published literature. PLoS One, 2012. 7(4): p. e34625.
62.Sheng, X., et al., MTHFR C677T polymorphism contributes to colorectal cancer susceptibility: evidence from 61 case-control studies. Mol Biol Rep, 2012. 39(10): p. 9669-79.
63.Mustapha, M.A., et al., Risk modification of colorectal cancer susceptibility by interleukin-8 -251T>A polymorphism in Malaysians. World J Gastroenterol, 2012. 18(21): p. 2668-73.
64.Yang, L., et al., TNF-beta +252 A>G polymorphism and susceptibility to cancer. J Cancer Res Clin Oncol, 2013. 139(5): p. 765-72.

QRCODE
 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                               
第一頁 上一頁 下一頁 最後一頁 top
無相關論文